Partnering opportunity

Spanish biotech company offers testing services for telomere diagnostics

Summary

Founded in 2010, the Spanish biotech company is a world leader in telomere diagnostics for clinical use in oncology and preventive and personalized medicine. With headquarters in Madrid, (Spain) they are an industry-leading biotechnology company working to improve people’s health and lifestyle. The types of partnerships considered by the company include financial agreements, joint venture agreements and services agreements worldwide.

Technical Specification or Expertise Sought

The company is seeking partners in the field of diagnostic oncology for prostate and lung cancer companies from the pharma, biotech /life sciences and nutraceutical companies -for in vitro and in vivo testing and studies- as well as personalized and preventive medicine companies. The types of partnerships considered are financial agreements, joint venture agreements and services agreements.

Partner sought

The company is seeking companies in the fields of diagnostic oncology for prostate and lung cáncer from the pharma, biotech /life sciences and nutraceutical areas, as well as personalized and preventive medicine companies to establish service, financial or joint venture agreements.

Description

The analytical validation and the certification of the test under Clinical Laboratory Improvement Amendments (CLIA-88) and International Organization for Standardization (ISO-15189) were completed in June 2016 and all the critical aspects of the test are controlled and supervised accordingly. Moreover, their laboratories had in situ reviews by regulators in 2017 and 2018 with reaccreditation and satisfactory results. The company has applied for patents and is expecting to have CE (European Conformity) marking and the International Organization for Standardization (ISO-13485) certification. The company is expecting accreditation from the European Medicines Agency (EMA) for the use of its test in prostate cancer screening in 2019 and approval in the U.S. through the Food and Drug Administration (FDA) as an In Vitro Diagnostic (IVD) with similar pathway for lung cancer screening to commence in 2020. They also offer testing services to physicians and individuals, researchers and corporations across many industries and regions, developing the adoption of telomeres and telomerase activity as key health biomarkers, advancing towards better and longer lifespans. The company is seeking partners in the field of diagnostic oncology for prostate and lung cancer companies from the pharma, biotech /life sciences and nutraceutical companies -for in vitro and in vivo testing and studies- as well as personalized and preventive medicine companies. The types of partnerships considered are financial agreements, joint venture agreements and services agreements.

Advantages and innovations

The Company is accredited with Clinical Laboratory Improvement Amendments (CLIA) and International Organization for Standardization (ISO) regulations, and their telomere analysis technology is focused on oncology diagnostics and prognostics. The strongest points of Telomere Analysis Technology and its quality assurance are based on the fine-tuning of the conditions required to optimize and guarantee: Accuracy; Precision Limit of Detection and Specificity. In addition, they have included a new, comprehensive data base reportable ranges and reference ranges. The company´s technology platform has the potential to become broadly applicable on a wide range of diseases, whenever the combination of disease specific Telomere-Associated Variables (TAV’s) can be combined with disease specific clinical data into a sharp cut-off algorithm for risk scoring of that disease (diagnosis or prognosis). Moreover, a EU Horizon 2020 research and innovation programme granted the Company with two-year studies involving over 6,000 patients to validate the Telomere-Associated Variables (TAV’s) as cancer biomarkers in prostate and lung cancer for screening and diagnosis and prognosis in leukemia.

Development stage

Already on the market

Intellectual Property Rights (IPR)

Secret Know-how,Patent(s) applied for but not yet granted,Trade Marks


Register your interest

How it works

  • Tell us about yourself
  • We’ll discuss with you
  • We put the right partners in touch

EEN help you find the right partner, rather than you going it alone.

Our role is to review and collate the most suitable submissions, and then send them to the client who posted the opportunity. We consult with you, and the client, to make the process professional and easy.

These are live opportunities. Your registration of interest on the site is just like a professional approach to a business at a networking event. To stand the best chance of success, make your submission really sing. Sell why the client who posted the opportunity should work with you. Excite them. Ask questions. Try and avoid copy and pasting words from elsewhere.

Once the client has chosen their partner, we'll introduce them over email and keep in touch with both parties to see how it's going. Sometimes things progress quickly. Sometimes because of changing priorities for either party, things progress slowly, but you never know - your next big business break could start right here.

?What value does EEN add?
This is your pitch: remember to include your unique selling points (USP) and why someone would want to do business with you
Tell us why you are a good fit for this opportunity, and why you think you're the right people for this partnership
If there's anything additional, or commercially sensitive you'd like to know about this opportunity, please let us know

When you entered your email address above, we emailed you a code to verify you're human and have access to that account.

?What's this?

What next?

To finish up, we just need some extra details about you and your company